Natural Products
| Catalog No. | Information |
| CFN93167 | Asperosaponin IV Reference standards. |
| CFN93170 | 5,6-Dehydroginsenoside Rd Reference standards. |
| CFN93171 | Euojaponine D Reference standards. |
| CFN93172 | Aurantio-obtusin beta-D-glucoside Reference standards. |
| CFN93173 | Decursinol angelate Decursinol angelate has anti-tumor, anti-inflammatory, anti-oxidant, and hepatoprotective activities, it inhibits VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway; it also suppresses invasion and inflammatory activation of cancer cells through modulation of PI3K/AKT, ERK and NF-kappaB, its anti-inflammatory activity may contribute to its anti-cancer activity.Decursinol angelate has protective effects against amyloid β-protein-induced oxidative stress in the PC12 cell line. It improves wound healing by upregulating the expression of genes encoding extracellular matrix remodeling proteins, inflammatory cytokines, and growth factors. Decursinol angelate has in vitro and in vivo antifungal activity against Magnaporthe oryzae, the causal agent of rice blast. |
| CFN93174 | Perisesaccharide C Reference standards. |
| CFN93175 | Ophiopogonanone B Reference standards. |
| CFN93176 | Neoastragaloside I Reference standards. |
| CFN93177 | Isoastragaloside IV Reference standards. |
| CFN93178 | Pseudoginsenoside Rh2 Pseudoginsenoside Rh2 has cytotoxicity, it induces mitochondrial apoptosis in A549 cells and is responsible for excessive activation of the Ras/Raf/ERK/p53 pathway. (20Z) -Pseudoginsenoside Rh2 and (20E)-Pseudoginsenoside Rh2 have antioxidative activity. |
| CFN93179 | Tenuifoliside B Tenuifoliside B is a target lactate dehydrogenase inhibitor. Tenuifoliside B has cognitive improving and cerebral protective effects. it can inhibit potassium cyanide (KCN)-induced hypoxia and scopolamine-induced memory impairment in mice. |
| CFN93183 | Tenuifoliside C Tenuifoliside C is a target lactate dehydrogenase inhibitor, it significantly inhibits chlorzoxazone 6-hydroxylation catalyzed by CYP2E1. |
| CFN93184 | Flemiphilippinin A Flemiphilippin A has antioxidant activity, it shows DPPH radical scavenging activity with effective half maximal concentration (EC50) of 18.36 ug/mL. Flemiphilippinin A (5 ug/mL) exhibits some level of antitumor activity against human hepatocellular carcinoma cell (BEL-7402), human lung epithelial (A-549) and human ileocecal adenocarcinoma cell (HCT-8). |
| CFN93185 | 2,3,4,5-Tetracaffeoyl-D-glucaric acid 2,3,4,5-Tetracaffeoyl-D-glucaric acid appears as an inhibitor of reactive oxygen species production by stimulated neutrophils. |
| CFN93186 | Licochalcone D Licochalcone D has anti-inflammatory, and anti-allergic activities, it shows suppression ability of nitric oxide (NO) production, it also suppresses degranulation by decreasing the intracellular Ca2+ level and tyrosine phosphorylation of ERK in RBL-2H3 cells. Licochalcone D has cardioprotective potential against myocardial ischemia/reperfusion injury in langendorff-perfused rat hearts. It may be a potential drug for human melanoma treatment by inhibiting proliferation, inducing apoptosis via the mitochondrial pathway and blocking cell migration and invasion. |
| CFN93188 | Plantainoside D Plantainoside D shows potent antioxidative effects as those of ascorbic acid, it shows angiotensin-converting enzyme (ACE) inhibitory inhibitory activity in vitro with the IC(50) value of 2.17 mM, it also shows inhibitory activity against PKCalpha with the IC50 value (in microM) of 14.8. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation. |
| CFN93189 | Ligupurpuroside A Ligupurpuroside A has antioxidant,and hypolipidemic effects, it can significantly inhibit lipid accumulation in HepG2 cell at the concentration of 50 umol/L. |
| CFN93190 | Ligupurpuroside B Ligupurpuroside B has antioxidant activity. |
| CFN93192 | Kanzonol C Kanzonol C has antimicrobial activity, it also shows potent PTP1B inhibitory activity (IC50 value of 0.31-0.97uM). Kanzonol C has chemopreventive activity,it shows the inhibition of matrix metalloproteinase (MMP)-2 secretion from brain tumor-derived glioblastoma cells. |
| CFN93193 | Vinaginsenoside R4 Vinaginsenoside R4 has melanogenic inhibitory activity, it may have potential as a new skin whitening compound. |
| CFN93194 | Vinaginsenoside R3 Reference standards. |
| CFN93195 | Vinaginsenoside R8 Reference standards. |
| CFN93197 | Gypenoside A Reference standards. |
| CFN93198 | Segetalin A Segetalin A has estrogen-like activity. |
| CFN93200 | Anemarrhenasaponin I Anemarrhenasaponin I shows remarkable inhibiting effect on platelet aggregation. |
| CFN93201 | Uvarigranol B Reference standards. |
| CFN93202 | Lucidenic acid B Lucidenic acid B shows antioxidative, and anti-invasive effects, it inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Lucidenic acid B also has chemopreventive potential, it induces apoptosis in human leukemia cells via a mitochondria-mediated pathway. |
| CFN93203 | Isoginsenoside Rh3 Reference standards. |
| CFN93204 | Uvarigranol C Reference standards. |
| CFN93205 | Scabioside C Reference standards. |
| CFN93206 | Clemastanin A Reference standards. |
| CFN93209 | Sibirioside A Reference standards. |
| CFN93210 | Kudinoside D Kudinoside D exerts anti-adipogenic effects through modulation of adipogenic transcription factors via AMPK signaling pathway. |
| CFN93214 | Gambogellic acid Gambogellic acid has cytotoxic activity, it exhibits inhibitory effect against SMMC-7221cell and A549 cell. |
| CFN93218 | Corynoxine B Corynoxine B, a natural autophagy inducer, restores the deficient cytosolic translocation of HMGB1 and autophagy in cells overexpressing SNCA, which may be attributed to its ability to block SNCA-HMGB1 interaction. Corynoxine B exhibits prolongation of the thiopental-induced hypnosis on oral administration in mice. |
| CFN93219 | Bacopasaponin C Bacopasaponin C may have antioxidant activity, it also shows anti-leishmanial property. |
| CFN93220 | Nuezhenidic acid Reference standards. |
| CFN93223 | Caesappanin C Caesappanin C exhibits a proliferation stimulating activity against primary osteoblastic cells. |
| CFN93224 | Siegesmethyetheric acid Reference standards. |
| CFN93225 | Glomeratose A Glomeratose A is a lactate dehydrogenase inhibitor. |
| CFN93226 | Jasminoside B Reference standards. |
| CFN93227 | 4'-O-Methylochnaflavone Reference standards. |
| CFN93228 | Raspberryketone glucoside Raspberry ketone glucoside has lasting effects for the inhibition of melanogenesis and various melanogenic factors after the degradation in the skin. |
| CFN93229 | 2-Hydroxy-6-methoxybenzoic acid Reference standards. |
| CFN93231 | Hederacolchiside E Hederacolchiside E has antioxidant activity, it shows inhibition on lipid peroxidation of linoleic acid emulsion; it may exert its anti-inflammatory effects by blocking bradykinin or other inflammation mediators. Hederacolchiside E shows neuroprotective effects in Alzheimer's disease (AD) models via modulating oxidative stress. |
| CFN93232 | Ginsenoside Rh7 Reference standards. |
| CFN93233 | 1-Methyl-6-oxopyridine-3-carboxylic acid Reference standards. |
| CFN93234 | Bacopaside II Bacopaside II is a potential anti-angiogenic agent, it can reduce endothelial cell migration and tubulogenesis and induce apoptosis. Bacopaside II shows antioxidant and antidepressant activities, it can inhibit both basal activity as well as verapamil-stimulated ATPase activity, suggesting its affinity towards P-gp. |
| CFN93235 | Aloenin A Aloenin and aloe-emodin are active principles for inhibition of c-ADH and c-ALDH activities in vitro. |
| CFN93236 | Epibetulinic acid Epibetulinic acid has anti-inflammatory activity, it exhibits potent inhibitory effects on NO and prostaglandin E(2) production in mouse macrophages (RAW 264.7) stimulated with bacterial endotoxin. |
